These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9387261)

  • 1. [Soluble interleukin-2 receptor in patients with urinary bladder cancer].
    Wen R; Xie S
    Zhonghua Zhong Liu Za Zhi; 1996 May; 18(3):224-6. PubMed ID: 9387261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Level and significance of the soluble interleukin-2 receptor expression in serum of patients with bladder cancer].
    Wen R; Xie S; Ma P
    Zhonghua Wai Ke Za Zhi; 1996 Jan; 34(1):16-8. PubMed ID: 9275680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of soluble Fas in the serum of patients with bladder cancer.
    Mizutani Y; Yoshida O; Bonavida B
    J Urol; 1998 Aug; 160(2):571-6. PubMed ID: 9679930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
    Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
    Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between serum levels of soluble interleukin-2 receptor and various disease parameters in patients with squamous cell carcinoma of the esophagus.
    Oka M; Hazama S; Takahashi M; Yamamoto K; Abe T; Yoshino S; Hayashi H; Tangoku A
    Hepatogastroenterology; 1999; 46(28):2254-9. PubMed ID: 10521976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum soluble interleukin-2 receptor levels in patients with renal cell carcinoma: a comparison of values before and after surgery].
    Tsukamoto S; Ishikawa S; Yamauchi A; Saitou S
    Hinyokika Kiyo; 2000 Oct; 46(10):695-9. PubMed ID: 11215193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression level of ligands for natural killer cell receptors predicts response to bacillus Calmette-Guerin therapy: a pilot study.
    Yutkin V; Pode D; Pikarsky E; Mandelboim O
    J Urol; 2007 Dec; 178(6):2660-4. PubMed ID: 17945285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of natural, interleukin-2 stimulated and bacillus Calmette-Guerin enhanced cytotoxicity with anti-CD16 antibodies.
    Kaasinen ES; Harju LM; Timonen TT
    J Urol; 2002 May; 167(5):2209-14. PubMed ID: 11956480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum soluble IL-2 receptor level in patients with sarcoidosis].
    Ina Y; Takada K; Noda M; Satou T; Hashiba H; Miyachi A; Ito S; Iijima N; Yamamoto M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Mar; 29(3):316-21. PubMed ID: 2067152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma].
    Shimomura Y; Tsurumi H; Sawada M; Yamada T; Hara T; Fukuno K; Goto H; Moriwaki H
    Rinsho Ketsueki; 1999 Aug; 40(8):639-45. PubMed ID: 10496038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma.
    Boyano MD; Garcia-Vázquez MD; López-Michelena T; Gardeazabal J; Bilbao J; Cañavate ML; Galdeano AG; Izu R; Díaz-Ramón L; Raton JA; Díaz-Pérez JL
    Br J Cancer; 2000 Oct; 83(7):847-52. PubMed ID: 10970683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The level of soluble interleukin 2 receptor in esophageal carcinoma patients before and after radiotherapy].
    Liu X; An H; Jiang Y
    Zhonghua Zhong Liu Za Zhi; 1995 Mar; 17(2):97-9. PubMed ID: 7656815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of soluble interleukin-2 receptor in patients with ANCA-associated vasculitis.
    Arranz O; Ara J; Rodríguez R; Saurina A; Mirapeix E; Darnell A
    J Nephrol; 2000; 13(1):59-64. PubMed ID: 10720216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes of serum interleukin 2 and soluble interleukin 2 receptor and their clinical significance in multiple myeloma].
    Wang Z; Li D; Yang J
    Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):439-41. PubMed ID: 9387297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.
    Kitaoka S; Shiota G; Kawasaki H
    Hepatogastroenterology; 2003; 50(53):1569-74. PubMed ID: 14571788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Soluble interleukin 2 receptor (sIL-2R) in patients with esophageal carcinoma].
    Duan ZF
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):17-9. PubMed ID: 8334935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cyclosporine A on serum and urinary soluble interleukin-2 receptor in patients with lupus nephritis.
    Tang Z; Zhang J; Zhang S; Li L
    Chin Med J (Engl); 1997 Sep; 110(9):686-9. PubMed ID: 9642325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dynamic studies of NK activity, IL-2 production and sIL-2R expression in primary hepatic carcinoma patients before and after operation].
    Cao YY
    Zhonghua Zhong Liu Za Zhi; 1993 Mar; 15(2):111-3. PubMed ID: 8223118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microinvasive Nd:YAG laser therapy of early glottic carcinoma and its effect on soluble interleukin-2 receptor, interleukin-2, and natural killer cells.
    Lai JP; Tao ZD; Xiao JY; Chen XH; Zhao SP; Tian YQ; Betz CS
    Laryngoscope; 2001 Sep; 111(9):1585-8. PubMed ID: 11568609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum soluble IL-2 receptor as a reliable and noninvasive marker of disease activity in patients with hairy cell leukemia.
    Chrobák L; Podzimek K; Plísková L; Kerekes Z; Zák P; Voglová J; Spacek J; Palicka V
    Neoplasma; 1996; 43(5):321-5. PubMed ID: 8996552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.